Stephen Quake, DPhil
Dr. Quake is the Lee Otterson Professor at Stanford University and is co- President of the Chan Zuckerberg Biohub, president of the CZ Biohub Network, and most recently Head of Science of the Chan Zuckerberg Initiative. His distinguished research career has spanned the gamut from biotechnology tools to novel diagnostics to therapeutics. The practical applications of Dr. Quake’s research have led to more than 130 issued U.S. patents, as well as numerous international patents. Quake is an active entrepreneur who has founded or co-founded several companies, including Fluidigm (IPO), Helicos (IPO), Verinata Health (acquired by Illumina), Moleculo (acquired by Illumina), Immumetrix (merged with XdX followed by IPO as CareDX), Quanticel Pharmaceuticals (acquired by Celgene), Cellular Research (acquired by Becton Dickinson), Karius (private), Agenovir (acquired by Vir) and Molecular Stethoscope (private). Dr. Quake received his doctorate degree at Oxford University in England and completed his post-doctoral fellowship at Stanford University.